Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3106 AL 3120

Case report of first-episode psychotic symptoms in a patient with early-onset Alzheimer's disease

Li X, Xiong Z, Liu Y, Yuan Y, Deng J, Xiang W, Li Z.

BMC Psychiatry. 2020 Mar 17;20(1):128. doi: 10.1186/s12888-020-02537-9.

Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues

Candasamy M, Mohamed Elhassan SA, Kumar Bhattamisra S, Hua WY, Sern LM, Binti Busthamin NA, Mohamad Ilni NB, Shun NS, Baohong L, Ya NS, Ying NW.

Panminerva Med. 2020 Sep;62(3):155-163. doi: 10.23736/S0031-0808.20.03879-3. Epub 2020 Mar 23.

The Challenge of Antidepressant Therapeutics in Alzheimer's Disease

Lozupone M, La Montagna M, D'Urso F, Piccininni C, Rinaldi A, Beghi M, Cornaggia CM, Sardone R, Solfrizzi V, Daniele A, Seripa D, Giannelli G, Bellomo A, Panza F.

Adv Exp Med Biol. 2020;1260:267-281. doi: 10.1007/978-3-030-42667-5_10.

A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease

Henderson ST, Morimoto BH, Cummings JL, Farlow MR, Walker J.

J Alzheimers Dis. 2020;75(2):547-557. doi: 10.3233/JAD-191302.

Protocol for an embedded pragmatic clinical trial to test the effectiveness of Aliviado Dementia Care in improving quality of life for persons living with dementia and their informal caregivers

Bristol AA, Convery KA, Sotelo V, Schneider CE, Lin SY, Fletcher J, Rupper R, Galvin JE, Brody AA.

Contemp Clin Trials. 2020 Jun;93:106005. doi: 10.1016/j.cct.2020.106005. Epub 2020 Apr 19.

Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer's Disease

Dogra A, Narang RS, Narang JK.

Curr Pharm Des. 2020;26(19):2257-2279. doi: 10.2174/1381612826666200422092620.

The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study

Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L, Lind G, Linderoth B, Seiger Å, Teipel S, Wahlberg LU, Wahlund LO, Westman E, Eriksdotter M; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2020 May 6;12(1):51. doi: 10.1186/s13195-020-00620-7.

Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery

Hampel H, Vergallo A, Caraci F, Cuello AC, Lemercier P, Vellas B, Giudici KV, Baldacci F, Hänisch B, Haberkamp M, Broich K, Nisticò R, Emanuele E, Llavero F, Zugaza JL, Lucía A, Giacobini E, Lista S; Alzheimer Precision Medicine Initiative.

Neuropharmacology. 2021 Mar 1;185:108081. doi: 10.1016/j.neuropharm.2020.108081. Epub 2020 May 11.

Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate

van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB.

Am J Geriatr Psychiatry. 2021 Jan;29(1):51-62. doi: 10.1016/j.jagp.2020.04.026. Epub 2020 May 5.

Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial

Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Dodel R, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A, Shah-Hosseini K, Teipel S, von Arnim CAF, Wiltfang J, Jessen F.

JAMA Netw Open. 2020 May 1;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027.

Evidence on the New Drug Lumateperone (ITI-007) for Psychiatric and Neurological Disorders

Mazza M, Marano G, Traversi G, Sani G, Janiri L.

CNS Neurol Disord Drug Targets. 2020;19(4):243-247. doi: 10.2174/1871527319666200601145653.

The impact of tamsulosin on cognition in Alzheimer disease with benign prostate hyperplasia: A study using the Hallym Smart Clinical Data Warehouse

Sohn JH, Lee SH, Kwon YS, Kim JH, Kim Y, Lee JJ.

Medicine (Baltimore). 2020 May 29;99(22):e20240. doi: 10.1097/MD.0000000000020240.

Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial

Traini E, Carotenuto A, Fasanaro AM, Amenta F.

J Alzheimers Dis. 2020;76(1):317-329. doi: 10.3233/JAD-190623.

Effects of Citicoline as an Adjunct Treatment for Alzheimer's Disease: A Systematic Review

Piamonte BLC, Espiritu AI, Anlacan VMM.

J Alzheimers Dis. 2020;76(2):725-732. doi: 10.3233/JAD-200378.

Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments

Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE.

Am J Geriatr Psychiatry. 2021 Jan;29(1):81-89. doi: 10.1016/j.jagp.2020.05.020. Epub 2020 May 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias